Biologics and immunotherapyIL-33trap is a novel IL-33–neutralizing biologic that inhibits allergic airway inflammation
-
Add time:09/05/2019 Source:sciencedirect.com
BackgroundThe emergence of IL-33 as a key molecular player in the development and propagation of widespread inflammatory diseases, including asthma and atopic dermatitis, has established the need for effective IL-33–neutralizing biologics.
We also recommend Trading Suppliers and Manufacturers of Red 33 (cas 1342-94-5). Pls Click Website Link as below: cas 1342-94-5 suppliers
Prev:Interleukin-33 reduces neuronal damage and white matter injury via selective microglia M2 polarization after intracerebral hemorrhage in rats
Next:Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation09/06/2019
- Interleukin-33 reduces neuronal damage and white matter injury via selective microglia M2 polarization after intracerebral hemorrhage in rats09/04/2019
- IL-33 contributes to disease severity in Psoriasis-like models of mouse09/03/2019
- Preparative separation and identification of novel subsidiary colors of the color additive D&C Red No. 33 (Acid Red 33 (cas 1342-94-5)) using spiral high-speed counter-current chromatography☆09/02/2019
- Chapter 33 - Red Sour Cherry for the Treatment of Diabetes Mellitus09/01/2019
- Chapter 33 - Red Blood Cells Products08/31/2019
- Red 33 (cas 1342-94-5) dye co-encapsulated with cetyltrimethylammonium in mesoporous silica materials08/30/2019
